"Vivek S. Kavadi Named New CEO of ASTRO"
Vivek S. Kavadi, MD, MBA, FASTRO, a distinguished radiation oncologist, has been appointed as the new Chief Executive Officer of the American Society for Radiation Oncology (ASTRO). Kavadi, a longtime ASTRO fellow, will be assuming his new role on November 1, taking over from the retiring CEO Laura Thevenot.
Extensive Clinical Experience and Leadership
With a focus on breast and prostate cancers, Kavadi has been actively involved in the field since 1995. He currently holds the position of Chief Radiation Oncology Officer for The US Oncology Network and has been instrumental in advancing cancer care at Texas Oncology.
In a statement, Kavadi expressed his gratitude for the opportunity to lead ASTRO, acknowledging the legacy left by his predecessor, Laura Thevenot. He emphasized his commitment to furthering collaboration, scientific progress, and excellence within the specialty.
Exceptional Educational Background and Professional Achievements
Kavadi earned his medical degree from Harvard School of Medicine and holds an MBA from The Wharton School, University of Pennsylvania. His training at The University of Texas MD Anderson Cancer Center, where he also served as a faculty member, equipped him with the skills and expertise necessary to drive innovation and growth within the field.
Praise from ASTRO Board of Directors
Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, commended Kavadi's appointment, highlighting the significance of having a leader with hands-on experience in clinical practice. He expressed confidence in Kavadi's ability to navigate the challenges faced by physicians and underscored his strategic vision for the future of ASTRO.
With Vivek S. Kavadi at the helm, ASTRO is poised to enter a new era of excellence and advancement in the field of radiation oncology."